Actuated Medical

Executive Summary

Actuated Medical is a privately-held medical device company based in Bellefonte, Pennsylvania, focused on improving patient outcomes in brain access and drug delivery. Founded in 2008, the company has developed the NeuralGlider platform, a patented technology that integrates precisely controlled motion to enhance the safety and efficacy of procedures involving the brain. The platform addresses critical unmet needs in neurosurgery and neurological therapy delivery, offering a less invasive, more accurate alternative to conventional manual or rigid tools. By enabling smoother, more controlled insertion of probes, catheters, and electrodes, NeuralGlider aims to reduce tissue trauma and improve procedural outcomes. The company is currently in the pre-clinical stage, validating its technology for initial human use. With a strong IP portfolio and a focused strategy on partnering with brain therapy and interface developers, Actuated Medical is well-positioned to capture value in the growing neuromodulation and neurosurgical markets. The NeuralGlider’s potential to enhance precision and safety aligns with increasing demand for minimally invasive brain interventions. While still early-stage, the technology’s differentiation and clear clinical need provide a solid foundation for future growth, pending successful completion of regulatory milestones and capital raises.

Upcoming Catalysts (preview)

• Q3 2026Series A Financing Round70% success
• Q4 2026FDA Breakthrough Device Designation60% success
• Q2 2027First-in-Human Clinical Trial Initiation50% success